A research paper on CHO-MK, a novel host cell line for biopharmaceutical manufacturing,  co-authored by Principal BioEngineer Michi Kubota, Senior BioEngineer Chigusa Iwama, and Chief Technology Officer Takayuki Horiuchi of Chitose Laboratory Corp., has been awarded the 2025 Excellent Paper Award from the Society of Biotechnology, Japan. This prestigious award recognizes papers that have significantly contributed to the advancement of biotechnology.

The award ceremony and commemorative lecture are scheduled to take place during the 77th Annual Meeting of the Society of Biotechnology, Japan, to be held from September 10 to 12.

The paper will be available with free access for one year starting Monday, July 14, 2025, and can be accessed via the link below:
➤Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing

Overview
Paper: Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing
Award name: 2025 Excellent Paper Award
Award Date: Thursday, May 22, 2025
Authors: Michi Kubota, Chigusa Iwama, Takayuki Horiuchi
Organizer: The Society of Biotechnology, Japan (SBJ)

About CHITOSE Stable Cell Line Development Service
https://chitose-bio.com/cld-service
Through over 10 years of research, CHITOSE has developed the highly productive CHO-MK host cell line and designed the original Chitose Super CHO expression system (CS CHO). With the combination of these innovations, we have established an extremely robust and flexible system to address the needs for a faster and more cost-effective cell line-based protein expression platform.

Related Information
[External] The Society of Biotechnology, Japan: Excellent Paper Award – Selected Papers (2025)
[News] Research Paper Published on CHO-MK: Novel Host Cell Line for Biopharmaceutical Manufacturing